MERCURO, GIUSEPPE
 Distribuzione geografica
Continente #
EU - Europa 357.512
NA - Nord America 20.674
AS - Asia 7.080
SA - Sud America 1.242
AF - Africa 1.091
OC - Oceania 76
Continente sconosciuto - Info sul continente non disponibili 7
Totale 387.682
Nazione #
IT - Italia 352.798
US - Stati Uniti d'America 20.411
CN - Cina 2.780
SG - Singapore 2.609
UA - Ucraina 1.454
SE - Svezia 1.160
BR - Brasile 1.051
ZA - Sudafrica 809
GB - Regno Unito 560
DE - Germania 501
VN - Vietnam 435
FI - Finlandia 414
IN - India 297
FR - Francia 178
KR - Corea 163
CA - Canada 160
BD - Bangladesh 156
HK - Hong Kong 82
BE - Belgio 69
KE - Kenya 66
AR - Argentina 64
TR - Turchia 60
NL - Olanda 53
ID - Indonesia 52
ES - Italia 51
RU - Federazione Russa 50
PK - Pakistan 49
PL - Polonia 48
MX - Messico 45
SA - Arabia Saudita 44
ZM - Zambia 44
AU - Australia 41
AT - Austria 36
JP - Giappone 36
IQ - Iraq 32
AE - Emirati Arabi Uniti 29
PH - Filippine 28
IR - Iran 27
UG - Uganda 27
EC - Ecuador 26
CO - Colombia 25
NP - Nepal 24
MA - Marocco 23
MY - Malesia 21
UZ - Uzbekistan 20
PY - Paraguay 18
CL - Cile 17
IE - Irlanda 17
LK - Sri Lanka 15
NG - Nigeria 15
PE - Perù 15
GH - Ghana 14
GR - Grecia 14
IL - Israele 14
LT - Lituania 14
NZ - Nuova Zelanda 14
TN - Tunisia 14
KW - Kuwait 13
RO - Romania 13
FJ - Figi 12
KH - Cambogia 12
TW - Taiwan 12
VE - Venezuela 12
EG - Egitto 11
JO - Giordania 11
TZ - Tanzania 11
BG - Bulgaria 9
KZ - Kazakistan 9
MW - Malawi 9
NO - Norvegia 9
PT - Portogallo 9
TH - Thailandia 9
ZW - Zimbabwe 9
CU - Cuba 8
DZ - Algeria 7
EU - Europa 7
JM - Giamaica 7
MU - Mauritius 7
OM - Oman 7
UY - Uruguay 7
AZ - Azerbaigian 6
BO - Bolivia 6
CH - Svizzera 6
CR - Costa Rica 6
LC - Santa Lucia 6
RS - Serbia 6
CY - Cipro 5
ET - Etiopia 5
HN - Honduras 5
KG - Kirghizistan 5
MT - Malta 5
PG - Papua Nuova Guinea 5
PR - Porto Rico 5
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
HR - Croazia 4
LV - Lettonia 4
PA - Panama 4
QA - Qatar 4
SB - Salomone, isole 4
Totale 387.608
Città #
Cagliari 341.849
Uta 9.994
Fairfield 2.496
Woodbridge 1.746
Ashburn 1.631
Houston 1.368
Chandler 1.285
Singapore 1.186
Ann Arbor 1.137
Dallas 1.084
Wilmington 1.022
Seattle 957
Boardman 924
Cambridge 891
Nyköping 793
Jacksonville 772
Beijing 584
Dearborn 456
Nanjing 289
Los Angeles 269
Boston 251
Santa Clara 241
Hefei 223
Johannesburg 214
Helsinki 179
Shanghai 169
New York 164
Buffalo 162
San Diego 152
Seoul 147
Ho Chi Minh City 133
Dong Ket 104
The Dalles 103
Shenyang 99
São Paulo 97
Milan 91
Redwood City 89
Nanchang 88
Guangzhou 87
Hebei 80
Toronto 77
London 75
Hong Kong 73
Cape Town 72
Hanoi 70
Jiaxing 70
Pretoria 70
Tianjin 69
Changsha 67
Atlanta 60
Munich 60
Chicago 58
Redondo Beach 55
Council Bluffs 50
Norwalk 48
Mountain View 45
Brussels 43
Jinan 42
Lusaka 42
Brooklyn 40
Orange 38
Phoenix 38
Rio de Janeiro 34
Verona 34
Durban 33
Nuremberg 33
Nairobi 32
Auburn Hills 31
Chennai 31
Washington 31
Belo Horizonte 30
Tokyo 29
Montreal 28
Warsaw 28
Wuhan 28
Zhengzhou 28
Amsterdam 27
Dhaka 27
Columbus 26
Frankfurt am Main 26
Sassari 25
Kunming 23
Ningbo 23
Denver 22
Falls Church 22
Pune 22
Stockholm 22
Mumbai 21
Poplar 20
Ankara 19
San Francisco 19
Curitiba 18
Borås 17
Rome 17
Tashkent 17
Augusta 16
Jakarta 16
Manchester 16
Orem 16
Paris 16
Totale 375.791
Nome #
Early ischemia identification employing 2D speckle tracking selective layers analysis during dobutamine stress echocardiography 4.338
Metabolomic approach to profile functional and metabolic changes in heart failure 4.202
Pathophysiology of cardiotoxicity induced by nonanthracycline chemotherapy 4.142
Distinctive metabolomic fingerprint in scleroderma patients with pulmonary arterial hypertension 3.877
Endodontic infection and endothelial dysfunction are associated with different mechanisms in men and women 3.832
Timing of the negative effects of trastuzumab on cardiac mechanics after anthracycline chemotherapy 3.548
Blood metabolomic fingerprint is distinct in healthy coronary and in stenosing or microvascular ischemic heart disease 3.507
Contractile reserve in systemic sclerosis patients as a major predictor of global cardiac impairment and exercise tolerance 3.505
Heart rate variability shows different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype 3.432
Effects of an adapted physical training on functional status, body composition and quality of life in persons with spinal cord injury paraplegia: a pilot study 3.404
Metabolomics Profile of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors 3.352
Effects of metformin and exercise training, alone or in combination, on cardiac function in individuals with insulin resistance 3.303
Epicardial fat thickness, an emerging cardiometabolic risk factor, is increased in young adults born preterm 3.117
A new type of physical activity from an ancient tradition: the Sardinian folk dance "ballu sardu" 3.093
Metabolomic fingerprint of coronary blood in STEMI patients depends on the ischemic time and inflammatory state 3.078
Metaboreflex-mediated hemodynamic abnormalities in individuals with coronary artery disease without overt signs or symptoms of heart failure 3.028
A case of SAPHO syndrome with endodontic implications and treatment with biologic drugs 3.013
Effects of a mini-trampoline rebounding exercise program on functional parameters, body composition and quality of life in overweight women 3.012
Metabolomics and Cardiology: Toward the Path of Perinatal Programming and Personalized Medicine 2.974
Metabolomics and heart failure: a new and promising scientific approach 2.959
Cardiovascular effects, body composition, quality of life and pain after a Zumba® fitness program in Italian overweight women 2.919
Coronary Artery Disease 2.906
Nitrergic system and plasmatic methylarginines: Evidence of their role in the perinatal programming of cardiovascular diseases 2.864
Altered transmural contractility in postmenopausal women affected by cardiac syndrome X 2.797
Long-term Protective Effects of the Angiotensin Receptor Blocker Telmisartan on Epirubicin-induced Inflammation, Oxidative Stress and Myocardial Dysfunction 2.792
Pharmacological treatment of vagal hyperactivity, a rare but potentially fatal cause of sudden cardiac death 2.745
Effects of a nordic walking program on motor and non-motor symptoms, functional performance and body composition in patients with Parkinson's disease 2.735
Modelling chemotherapy-induced cardiotoxicity by human pluripotent stem cells 2.728
Sardinian Folk Dance for Individuals with Parkinson's Disease: A Randomized Controlled Pilot Trial 2.714
Cardioprotection by gene therapy: review paper on behalf of the Working Group on Drug Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology 2.712
Sex-related differential susceptibility to ponatinib cardiotoxicity and differential modulation of the Notch1 signalling pathway in a murine model 2.705
Metabolomic approach to redox and nitrosative reactions in cardiovascular diseases 2.673
Fully-textile polymer-based ECG electrodes: overcoming the limits of metal-based textiles 2.672
Metabolomics, a promising approach to translational research in cardiology 2.651
Zumba Fitness and Women’s Cardiovascular Health: A SYSTEMATIC REVIEW 2.526
Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry 2.506
Premature vascular deterioration in young patients affected by Wilson's disease: a pilot study 2.505
Aquatic exercise improves motor impairments in people with Parkinson's disease, with similar or greater benefits than land-based exercise: a systematic review 2.475
Improving the preclinical models for the study of chemotherapy-induced cardiotoxicity: a Position Paper of the Italian Working Group on Drug Cardiotoxicity and Cardioprotection 2.474
Impaired endothelial function in hereditary angioedema during the symptom-free period 2.391
Effects of Metformin Treatment on Myocardial and Endothelial Function in Insulin Resistance Patients: A Metabolomic Study. 2.367
Antioxidant approach as a cardioprotective strategy in chemotherapy-induced cardiotoxicity 2.357
Effects of an adapted physical activity program on motor and non-motor functions and quality of life in patients with Parkinson's disease 2.339
The perioperative dental screening and management of patients undergoing cardiothoracic, vascular surgery and other cardiovascular invasive procedures: A systematic review 2.274
A recommended practical approach to the management of target therapy and angiogenesis inhibitors cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology 2.273
Muscle MRI findings in patients with an apparently exclusive cardiac phenotype due to a novel LMNA gene mutation 2.259
Study of autonomic cardiovascular dysfunction in Parkinson’s disease patients with LRRK2 mutations using Heart Rate Variability 2.250
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry 2.235
null 2.211
null 2.190
Impaired central arterial elasticity in young adults born with intrauterine growth restriction 2.190
Metabolomic Analysis of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors 2.190
Ponatinib Induces Vascular Toxicity through the Notch-1 Signaling Pathway 2.185
Study on the correlation among total burden of nonmotor symptoms and cardiovascular dysmodulation in Parkinson’s disease patients 2.179
Inverted Takotsubo cardiomyopathy induced by dobutamine stress echocardiography with atypical presentation 2.146
Effects of an aquatic-based exercise program to improve cardiometabolic profile, quality of life, and physical activity levels in men with type 2 diabetes mellitus 2.144
Perioperative dental screening and treatment in patients undergoing cardio-thoracic surgery and interventional cardiovascular procedures. A consensus report based on RAND/UCLA methodology. 2.134
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world 2.131
Reply to comment on: “Nordic Walking for the Management of People with Parkinson Disease: A Systematic Review” 2.112
Autonomic imbalance in Parkinson's disease patients with or without LRRK2 gene mutations 2.112
Potential cardiac risk of immune-checkpoint blockade as anticancer treatment: What we know, what we do not know, and what we can do to prevent adverse effects 2.085
Muscle imaging analogies in a cohort of patients with different clinical phenotypes caused by LMNA gene mutations 2.078
Antineoplastic drug-induced cardiotoxicity: A redox perspective 2.072
IGENDA protocol: gender differences in awareness, knowledge and perception of cardiovascular risk: an Italian multicenter study 2.071
Abnormal atrial activation at surface electrocardiogram examination in born underweight young adults 2.062
Antihypertensive therapy in children: differences in medical approach between the United States and Europe 2.060
The need of a gender-corrected evidence based medicine 2.059
Trastuzumab-based adjuvant chemotherapy for breast cancer: Early myocardial dysfunction detected by "speckle tracking" echocardiography (STE). 2.047
Supervised aquatic-based exercise for men with coronary artery disease: a meta-analysis of randomised controlled trials 2.046
Clinical metabolomics and hematic ADMA predict the future onset of cardiorenal syndrome in young grown-up subjects who were born preterm 1.997
Association of endodontic infection with detection of an initial lesion to the cardiovascular system 1.955
Altered aortic upper wall TDI velocity is inversely related with left ventricular diastolic function in operated tetralogy of Fallot 1.952
Sex differences in anthracycline-induced cardiotoxicity: the benefits of estrogens 1.948
Could ADMA levels in young adults born preterm predict an early endothelial dysfunction? 1.941
Chemotherapy-induced cardiotoxicity: new insights into mechanisms, monitoring, and prevention 1.940
Apical periodontitis and cardiovascular diseases: previous findings and ongoing research 1.939
An old drug for use in the prevention of sudden infant unexpected death due to vagal hypertonia 1.930
Metabolic pathways in heart failure correlate with impaired longitudinal global strain rate 1.906
Ultrasound examination for the detection of simulated periapical bone lesions in bovine mandibles: an ex vivo study 1.891
Current views on anthracycline cardiotoxicity 1.884
Diabetic cardiomyopathy and ischemic heart disease: Prevention and therapy by exercise and conditioning 1.883
Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry 1.870
Arterial hypertension in the female world: Pathophysiology and therapy 1.850
Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry 1.825
Bridging the mortality gap: A new challenge in percutaneous coronary intervention for patients with cancer 1.823
Early right ventricular dysfunction in highly selected (totally free from cardiovascular risk factors and other comorbidities) human immunodeficiency virus patients: A pilot study with advanced echocardiography 1.789
Multimodality imaging diagnosis of multiple ventricular thrombosis and massive stroke after gemcitabine and cisplatin chemotherapy for Urothelial Cancer 1.768
Effects of metformin and exercise training, alone or in association, on cardio-pulmonary performance and quality of life in insulin resistance patients 1.756
Preventing antiblastic drug-related cardiomyopathy: Old and new therapeutic strategies 1.741
Gender differences in cardiology: is it time for new guidelines? 1.741
Metabolomic perspectives in antiblastic cardiotoxicity and cardioprotection 1.707
A systematic overview to quantify the gender imbalance in cardiovascular rehabilitation trials 1.689
Early diagnosis, clinical management, and follow-up of cardiovascular events with ponatinib 1.671
L’analisi metabolomica delle vie metaboliche nei pazienti affetti da scompenso cardiaco correla con lo strain rate longitudinale 1.670
A recommended practical approach to the management of anthracycline-based chemotherapy cardiotoxicity: An opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology 1.653
Persistence, up to 18 months of follow-up, of epirubicin-induced myocardial dysfunction detected early by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers 1.648
Cardiovascular prevention in women: A narrative review from the Italian Society of Cardiology working groups on 'Cardiovascular Prevention, Hypertension and peripheral circulation' and on 'Women Disease' 1.634
null 1.595
Impaired Forearm Blood Flow and Vasodilator Reserve in Healthy Postmenopausal Women 1.584
Gender-specific aspects in primary and secondary prevention of cardiovascular disease 1.584
Totale 240.828
Categoria #
all - tutte 501.632
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 501.632


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202137.115 0 0 0 0 0 9.937 6.930 5.608 2.372 4.709 4.333 3.226
2021/202218.526 2.175 1.204 956 1.607 1.395 1.332 989 1.155 1.895 1.689 1.954 2.175
2022/202326.476 2.651 3.900 3.513 2.267 2.246 2.258 1.128 2.121 1.730 1.465 2.036 1.161
2023/202430.921 1.668 1.166 1.376 2.261 3.046 4.843 4.853 2.585 1.702 2.132 2.768 2.521
2024/202555.265 10.433 13.562 9.788 6.654 3.121 4.922 3.911 375 708 521 587 683
2025/20267.495 956 784 2.130 1.444 1.292 889 0 0 0 0 0 0
Totale 388.712